Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes

Fig. 4

Corneal sensitivity as measured by force (g/mm2) required to elicit a blink response using the Cochet-Bonnet aesthesiometer. Diabetic rats (T1D) were treated in the right eye with Vigamox® + NTX, NTX-001 formulation, or buffer for 48 or 240 h. Baseline values for normal (N) rats and T1D rats are provided for comparison. Values represent means ± SEM. Significantly different from T1D baseline measurements at p < 0.05 (*) or p < 0.01 (**)

Back to article page